How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

101 results for

Dermatographism

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. Dermatographism

Dermatographism Dermatographism Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Dermatographism Dermatographism Aka: Dermatographism (...) a Bing search on the term "Dermatographism." Click on the image (or right click) to open the source website in a new browser window. Related Studies (from Trip Database) Ontology: Symptomatic dermographism (C0343065) Definition (NCI) A raised, inflamed skin reaction to pressure from rubbing or scratching.(NICHD) Concepts Disease or Syndrome ( T047 ) ICD9 708.3 ICD10 SnomedCT 123093003 , 7632005 , 238685008 , 201265007 , 270885004 , 156430003 , 201263000 , 247473009 , 402601007 , 402410006 English

2018 FP Notebook

2. Symptomatic dermatographism treated with narrowband UVB phototherapy. (PubMed)

Symptomatic dermatographism treated with narrowband UVB phototherapy. Dermatographism occurs when there is an exaggerated response to physical stimulus. There are both simple and symptomatic forms. Symptomatic dermatographsim can be exceedingly difficult to treat. Treatment modalities include H1 and H2 antagonists, leukotriene antagonists, cyclosporine and oral steroids. In a few small case series and studies, phototherapy has been used. We report a further two patients who were treated

2014 Journal of Dermatological Treatment

3. Dermatographism

Dermatographism Dermatographism Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Dermatographism Dermatographism Aka: Dermatographism (...) a Bing search on the term "Dermatographism." Click on the image (or right click) to open the source website in a new browser window. Related Studies (from Trip Database) Ontology: Symptomatic dermographism (C0343065) Definition (NCI) A raised, inflamed skin reaction to pressure from rubbing or scratching.(NICHD) Concepts Disease or Syndrome ( T047 ) ICD9 708.3 ICD10 SnomedCT 123093003 , 7632005 , 238685008 , 201265007 , 270885004 , 156430003 , 201263000 , 247473009 , 402601007 , 402410006 English

2015 FP Notebook

4. Dermatographic urticaria

Dermatographic urticaria Dermatographic urticaria - Wikipedia Dermatographic urticaria From Wikipedia, the free encyclopedia Dermatographic urticarial D Dermatographic urticaria is sometimes called "skin writing". , Dermatographic urticaria (also known as dermographism , dermatographism or " skin writing ") is a skin disorder and one of the most common types of , affecting 2–5% of the population. Contents Signs and symptoms [ ] Self-referential illustration of dermatographic urticaria

2012 Wikipedia

5. Assessment of urticaria

, for example delayed pressure urticaria, heat urticaria, solar urticaria, symptomatic dermatographism, vibratory angio-oedema, aquagenic urticaria, cholinergic urticaria, and contact urticaria. Some people have urticaria that is complicated by angio-oedema, a swelling of the deeper dermis and tissues (e.g., mucosal surfaces), with laryngeal oedema potentially causing respiratory distress and death. Zuberbier T, Aberer W, Asero R, et al. The EAACI/GA(2)LEN/EDF/WAO guideline for the definition

2018 BMJ Best Practice

6. Assessment of urticaria

, for example delayed pressure urticaria, heat urticaria, solar urticaria, symptomatic dermatographism, vibratory angio-oedema, aquagenic urticaria, cholinergic urticaria, and contact urticaria. Some people have urticaria that is complicated by angio-oedema, a swelling of the deeper dermis and tissues (e.g., mucosal surfaces), with laryngeal oedema potentially causing respiratory distress and death. Zuberbier T, Aberer W, Asero R, et al. The EAACI/GA(2)LEN/EDF/WAO guideline for the definition

2018 BMJ Best Practice

7. The Effect of Levocetirizine on Inflammatory Mediators in Dermatographism

The Effect of Levocetirizine on Inflammatory Mediators in Dermatographism The Effect of Levocetirizine on Inflammatory Mediators in Dermatographism - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. The Effect (...) of Levocetirizine on Inflammatory Mediators in Dermatographism The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT01008592 Recruitment Status : Terminated (Mediators of interest were not consistently detectable with the analytical methods employed.) First Posted : November 6, 2009 Last Update Posted : February 28

2009 Clinical Trials

8. CRACKCast E120 – Dermatologic presentations

nonimmunologic) ASA Penicillin Narcotics Food related Skin irritants: Foods, clothing fabrics, animal/plants, chemicals, cosmetics, cold/heat Physical urticaria: Dermatographism Cholinergic urticaria: induced by exercise, heat, or emotional stress. It may be associated with pruritus, nausea, abdominal pain, and headache. Inhalation irritants Pollens, mold, dander, dust Stings/bites Systemic disease: systemic lupus erythematosus, lymphoma, carcinoma, hyperthyroidism, rheumatic fever, and juvenile rheumatoid

2017 CandiEM

11. Peanut Oral Immunotherapy Study of Early Intervention for Desensitization

); or symptoms of dysphagia (eg, difficulty swallowing, food "getting stuck"). History of a mast cell disorder including mastocytosis, urticaria pigmentosa, chronic idiopathic or chronic physical urticaria beyond simple dermatographism. Mild asthma that is uncontrolled or difficult to control. Moderate or severe persistent asthma. History of food protein‑induced enterocolitis syndrome . History of chronic disease that is or is at significant risk of becoming unstable or requiring a change in a chronic

2018 Clinical Trials

12. Characterization of the Molecular Mechanisms Involved in Delayed-Type Hypersensitivity Reactions to House Dust Mite, Diphencyprone, Nickel, and Tuberculin Purified Protein Derivative in Healthy Volunteers

pregnant during the study. Subject has a known history of severe allergic reaction (local or systemic) to the tested hapten. Subject has a history of skin disease or presence of skin condition that, in the opinion of the investigator, would interfere with the study assessments including active urticaria, psoriasis, atopic dermatitis, active contact dermatitis and excited (angry back) skin syndrome. Medical history of dermatographism. History of contact dermatitis to medical adhesive bandages or glue (...) during the study. Subject has a known history of severe allergic reaction (local or systemic) to the tested hapten. Subject has a history of skin disease or presence of skin condition that, in the opinion of the investigator, would interfere with the study assessments including active urticaria, psoriasis, atopic dermatitis, active contact dermatitis and excited (angry back) skin syndrome. Medical history of dermatographism. History of contact dermatitis to medical adhesive bandages or glue. Presence

2018 Clinical Trials

13. A Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of Single and Multiple Ascending Doses of GDC-0334 and the Effect of Food on the Pharmacokinetics of GDC-0334 in Healthy Adult Participants

(msec) demonstrated by at least two ECGs >30 minutes apart History of ventricular dysrhythmias or risk factors for ventricular dysrhythmias such as structural heart disease, coronary heart disease (symptomatic or with ischemia demonstrated by diagnostic testing), clinically significant electrolyte abnormalities, or family history of sudden unexplained death or long QT syndrome Current treatment with medications that are well known to prolong the QT interval History of dermatographism Presence

2017 Clinical Trials

14. ARTEMIS Peanut Allergy In Children

), other eosinophilic gastrointestinal disease, chronic, recurrent, or severe gastroesophageal reflux disease (GERD), symptoms of dysphagia or recurrent gastrointestinal symptoms of undiagnosed etiology History of a mast cell disorder, including mastocytosis, urticaria pigmentosa, chronic idiopathic or chronic physical urticaria beyond simple dermatographism (e.g., cold urticaria, cholinergic urticaria), and hereditary or idiopathic angioedema Any other condition that, in the opinion

2017 Clinical Trials

15. To Assess the Mildness of a Cosmetic Cleanser in Healthy Participants Using the Forearm-Controlled Application Technique (FCAT)

, pimples, or cysts at the application site. Active dermatosis (local or disseminated) that might interfere with the results of the study. Considered immune compromised. History of diseases aggravated or triggered by ultraviolet radiation. History of atopic dermatitis. Participants with dermatographism. Currently using any medication which in the opinion of the investigator, may affect the evaluation of the study product, or place the participant at undue risk. Use of the following topical or systemic

2017 Clinical Trials

16. To Investigate Primary Irritation Potential of Four Skin Serum Products on Human Subjects Assessed by 24 Hour Patch Test

with the evaluation of the test site reaction. Presence of open sores, pimples, or cysts at the application site. Active dermatosis (local or disseminated) that might interfere with the results of the study Considered immune compromised. History of diseases aggravated or triggered by ultraviolet radiation. Participants with dermatographism. Currently using any medication which in the opinion of the investigator, may affect the evaluation of the study product, or place the participant at undue risk. Use

2017 Clinical Trials

17. Evaluation of Safety and Efficacy of BBI-2000 in Treating and Preventing Contact Dermatitis

information Ages Eligible for Study: 18 Years to 65 Years (Adult, Older Adult) Sexes Eligible for Study: All Accepts Healthy Volunteers: Yes Criteria Inclusion Criteria: Individuals aged 18 to 65 years inclusive at the time of consent, and either female of non-reproductive potential or male. Subjects must be healthy, normal volunteers per physical exam, laboratory and EKG assessments Exclusion Criteria: History of contact dermatitis to medical adhesive bandages or glue. Medical history of dermatographism

2017 Clinical Trials

18. Real-World AR101 Market-Supporting Experience Study in Peanut-Allergic Children

(GERD), symptoms of dysphagia or recurrent gastrointestinal symptoms of undiagnosed etiology History of a mast cell disorder, including mastocytosis, urticaria pigmentosa, chronic idiopathic or chronic physical urticaria beyond simple dermatographism (e.g., cold urticaria, cholinergic urticaria), and hereditary or idiopathic angioedema Any other condition that, in the opinion of the Investigator, precludes participation for reasons of safety Contacts and Locations Go to Information from the National

2017 Clinical Trials

19. To Investigate the Cutaneous and Ocular Local Tolerance of Two Cosmetic Facial Cleanser in Healthy Females With Sensitive Skin

response (e.g. diabetes,) which could, in the opinion of the Investigator, preclude topical application of the investigational products and/or interfere with the evaluation of the test site reaction Presence of open sores, pimples, or cysts at the application site Active dermatosis (local or disseminated) that might interfere with the results of the study Considered immune compromised Participants with dermatographism Currently using any medication which in the opinion of the investigator, may affect

2017 Clinical Trials

20. To Assess the Cutaneous Irritation and Sensitization Potential of a Cosmetic Facial Product Using a Human Repeat Insult Patch Test (HRIPT) in Healthy Participants

with the evaluation of the test site reaction Presence of open sores, pimples, or cysts at the application site Active dermatosis (local or disseminated) that might interfere with the results of the study Considered immune compromised History of diseases aggravated or triggered by ultraviolet radiation Participants with dermatographism Currently using any medication which in the opinion of the investigator, may affect the evaluation of the study product, or place the participant at undue risk Use of the following

2017 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>